| Daniel Dilling, MD | |
|
2160 S First Ave, Fahey Bldg., Room 131a, Maywood, IL 60153 | |
| (708) 216-6850 | |
| (708) 216-6839 |
| Full Name | Daniel Dilling |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 26 Years |
| Location | 2160 S First Ave, Maywood, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659358539 | NPI | - | NPPES |
| 36104271 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 36104271 (Illinois) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 36104271 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loyola University Medical Center | Maywood, IL | Hospital |
| Northwest Community Hospital 1 | Arlington heights, IL | Hospital |
| Central Dupage Hospital | Winfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loyola University Medical Center | 3779488903 | 863 |
News Archive
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has acquired the exclusive worldwide development and commercialization rights to ASPAREC for the treatment of acute lymphoblastic leukemia (ALL) from Alizé Pharma.
While the White House seems destined to spend the next two years fending off attacks on President Obama's health care law, the administration of Governor Deval Patrick of Massachusetts will push forward with the next stage of health care overhaul: trying to contain the escalating costs of medical care.
Now, a team of scientists at the United Kingdom's Rosalind Franklin Institute may have a surprising solution for the coronavirus pandemic, which has killed more than 574,000 people worldwide.
Researchers have found a way in mice to convert another type of pancreas cell into the critical insulin-producing beta cells that are lost in those with type I diabetes. The secret ingredient is a single transcription factor, according to the report in the August 7th issue of Cell, a Cell Press journal.
› Verified 2 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has acquired the exclusive worldwide development and commercialization rights to ASPAREC for the treatment of acute lymphoblastic leukemia (ALL) from Alizé Pharma.
While the White House seems destined to spend the next two years fending off attacks on President Obama's health care law, the administration of Governor Deval Patrick of Massachusetts will push forward with the next stage of health care overhaul: trying to contain the escalating costs of medical care.
Now, a team of scientists at the United Kingdom's Rosalind Franklin Institute may have a surprising solution for the coronavirus pandemic, which has killed more than 574,000 people worldwide.
Researchers have found a way in mice to convert another type of pancreas cell into the critical insulin-producing beta cells that are lost in those with type I diabetes. The secret ingredient is a single transcription factor, according to the report in the August 7th issue of Cell, a Cell Press journal.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Dilling, MD 2160 S First Ave, Fahey Bldg., Room 131a, Maywood, IL 60153 Ph: (708) 216-6850 | Daniel Dilling, MD 2160 S First Ave, Fahey Bldg., Room 131a, Maywood, IL 60153 Ph: (708) 216-6850 |
News Archive
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has acquired the exclusive worldwide development and commercialization rights to ASPAREC for the treatment of acute lymphoblastic leukemia (ALL) from Alizé Pharma.
While the White House seems destined to spend the next two years fending off attacks on President Obama's health care law, the administration of Governor Deval Patrick of Massachusetts will push forward with the next stage of health care overhaul: trying to contain the escalating costs of medical care.
Now, a team of scientists at the United Kingdom's Rosalind Franklin Institute may have a surprising solution for the coronavirus pandemic, which has killed more than 574,000 people worldwide.
Researchers have found a way in mice to convert another type of pancreas cell into the critical insulin-producing beta cells that are lost in those with type I diabetes. The secret ingredient is a single transcription factor, according to the report in the August 7th issue of Cell, a Cell Press journal.
› Verified 2 days ago
Dr. Cathryn T Sawalski, DO, MBA Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Suhana Elamsenthil, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Holly Kramer, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2160 S First Ave, 101-1740 Loyola University Medical Center, Maywood, IL 60153 Phone: 708-216-9000 Fax: 708-216-9033 | |
Dr. Stephanie Bochen Tsai, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Nicholas Poellinger, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Sofia Ahmed, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-8757 | |
Shelly Lo, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Luh - North Ent., Rm. 7604, Maywood, IL 60153 Phone: 708-216-3304 Fax: 708-216-1259 |